Premium & sponsored content

Sponsored content

From time to time, Tellimer is contracted by an issuer to carry out a series of independent analyses on their company. This typically happens when the issuer believes that they are not covered enough by traditional sell-side research teams.

Leveraging Tellimer's independence

When an issuer sponsors Tellimer to analyse their company, Tellimer does not provide any investment recommendations on the company. The analysis carried out is not influenced by the sponsoring company and leverages Tellimer's reputation of fierce independence. Opinions published in the report represent those of the research department of Tellimer at the time of publication. The sponsor has no editorial input into the content of the analysis, and Tellimer's fees are not contingent on the sponsor’s approval of the research.

Previous
Premium content